Optimising adalimumab treatment in psoriasis with concomitant methotrexate.
Phase of Trial: Phase IV
Latest Information Update: 28 Nov 2017
Price : $35 *
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms OPTIMAP
- 02 Feb 2017 New source identified and integrated (European Clinical Trials Database :EudraCT 2013-004918-18)
- 02 Feb 2017 Trial design published in the Trials.
- 02 Jun 2014 New trial record